Logo image of SSY

SUNLINK HEALTH SYSTEMS INC (SSY) Stock Fundamental Analysis

NYSEARCA:SSY - American Stock Exchange - US86737U1025 - Common Stock - Currency: USD

0.8995  +0.04 (+4.3%)

After market: 0.8546 -0.04 (-4.99%)

Fundamental Rating

3

Taking everything into account, SSY scores 3 out of 10 in our fundamental rating. SSY was compared to 109 industry peers in the Health Care Providers & Services industry. While SSY has a great health rating, there are worries on its profitability. SSY has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SSY had negative earnings in the past year.
SSY had a negative operating cash flow in the past year.
SSY had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: SSY reported negative operating cash flow in multiple years.
SSY Yearly Net Income VS EBIT VS OCF VS FCFSSY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -3.73%, SSY is in line with its industry, outperforming 41.67% of the companies in the same industry.
SSY has a Return On Equity (-4.75%) which is in line with its industry peers.
Industry RankSector Rank
ROA -3.73%
ROE -4.75%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SSY Yearly ROA, ROE, ROICSSY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

Looking at the Gross Margin, with a value of 43.55%, SSY is in the better half of the industry, outperforming 70.37% of the companies in the same industry.
In the last couple of years the Gross Margin of SSY has declined.
SSY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.55%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.82%
GM growth 5Y-5.67%
SSY Yearly Profit, Operating, Gross MarginsSSY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

8

2. Health

2.1 Basic Checks

SSY does not have a ROIC to compare to the WACC, probably because it is not profitable.
SSY has more shares outstanding than it did 1 year ago.
SSY has more shares outstanding than it did 5 years ago.
There is no outstanding debt for SSY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SSY Yearly Shares OutstandingSSY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2023 2024 2M 4M 6M 8M
SSY Yearly Total Debt VS Total AssetsSSY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

SSY has an Altman-Z score of 2.74. This is not the best score and indicates that SSY is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of SSY (2.74) is better than 63.89% of its industry peers.
There is no outstanding debt for SSY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.74
ROIC/WACCN/A
WACC9.16%
SSY Yearly LT Debt VS Equity VS FCFSSY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 4.06 indicates that SSY has no problem at all paying its short term obligations.
The Current ratio of SSY (4.06) is better than 91.67% of its industry peers.
A Quick Ratio of 3.65 indicates that SSY has no problem at all paying its short term obligations.
The Quick ratio of SSY (3.65) is better than 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 4.06
Quick Ratio 3.65
SSY Yearly Current Assets VS Current LiabilitesSSY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2023 2024 5M 10M 15M 20M 25M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 59.79% over the past year.
The Revenue for SSY has decreased by -30.04% in the past year. This is quite bad
SSY shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.58% yearly.
EPS 1Y (TTM)59.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.96%
Revenue 1Y (TTM)-30.04%
Revenue growth 3Y-7.28%
Revenue growth 5Y-6.58%
Sales Q2Q%-7.39%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SSY Yearly Revenue VS EstimatesSSY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
SSY Yearly EPS VS EstimatesSSY Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SSY. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SSY Price Earnings VS Forward Price EarningsSSY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SSY Per share dataSSY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SSY!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SUNLINK HEALTH SYSTEMS INC

NYSEARCA:SSY (2/5/2025, 8:04:00 PM)

After market: 0.8546 -0.04 (-4.99%)

0.8995

+0.04 (+4.3%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)02-18 2025-02-18
Inst Owners13.46%
Inst Owner Change0%
Ins Owners22.63%
Ins Owner Change0%
Market Cap6.33M
Analysts0
Price TargetN/A
Short Float %2.34%
Short Ratio0.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.2
P/FCF N/A
P/OCF N/A
P/B 0.41
P/tB 0.44
EV/EBITDA N/A
EPS(TTM)-0.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.57
FCFYN/A
OCF(TTM)-0.39
OCFYN/A
SpS4.52
BVpS2.19
TBVpS2.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.73%
ROE -4.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.55%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.82%
GM growth 5Y-5.67%
F-Score3
Asset Turnover1.62
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 62.67%
Cap/Sales 3.86%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.06
Quick Ratio 3.65
Altman-Z 2.74
F-Score3
WACC9.16%
ROIC/WACCN/A
Cap/Depr(3y)133.35%
Cap/Depr(5y)134.66%
Cap/Sales(3y)5.57%
Cap/Sales(5y)5.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)59.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.96%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-30.04%
Revenue growth 3Y-7.28%
Revenue growth 5Y-6.58%
Sales Q2Q%-7.39%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-172.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-78.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-451.48%
OCF growth 3YN/A
OCF growth 5YN/A